市场调查报告书
商品编码
1305944
感染控制用品市场规模 - 按产品、按分销渠道、按最终用途,全球预测2023 - 2032年Infection Control Supplies Market Size - By Product, By Distribution Channel, By End-use, Global Forecast 2023 - 2032 |
到2032年,全球感染控制用品市场规模将显著扩大。医疗保健设施的快速扩张为市场扩张提供了显著动力。包括医院、诊所和长期护理设施在内的医疗基础设施不断扩大,增加了对感染控制用品的需求。随着新设施的建立或现有设施的发展,为这些场所配备必要的用品以保持无菌环境和防止感染传播的需求变得至关重要。
整个感染控制用品市场根据产品、分销渠道、终端用途和地区进行分类。
根据产品,清洁和消毒设备行业的规模将在2032年之前大幅扩大。导管获得性尿路感染的数量不断增加,与医院获得性感染相关的经济负担日益加重,为该细分市场的增长铺平了道路。据NCBI统计,仅在美国,每年就有约100万例导管相关性尿路感染(CAUTI)病例被确诊。此外,每年可预防的CAUTI的相关费用在1.15亿美元至18.2亿美元之间。
根据分销渠道,到2032年,电子商务领域的行业价值将大幅增长。由于其便利性和成本效益,客户越来越倾向于电子商务渠道,这促进了该细分市场的增长。此外,这些平台以优惠的价格提供各种感染控制用品,适合中产阶级人群。电子商务平台数量的增加进一步推动了细分市场的增长。
根据最终用途,医疗器械公司细分市场的行业份额将在2023年至2032年期间以超过6%的年复合增长率增长。美国FDA批准的消毒产品激增,增加了医疗器械公司对感染控制用品的需求。此外,医疗机构感染控制监管的收紧也进一步增加了这些机构对感染控制用品的采用。
从区域角度来看,欧洲感染控制用品市场规模到2032年将达到170多亿美元。随着老年人口的增加,慢性疾病的发病率也在上升,这也促进了该地区的增长。此外,Getinge Ab、Belimed Deutschland GmbH等行业巨头的蓬勃发展也有利于该地区的增长。此外,欧洲拥有完善的医疗基础设施,这将为行业增长提供支持。
Global Infection Control Supplies Market size will expand significantly through 2032. Rapid expansion of healthcare facilities is creating a notable impetus for market expansion. The expanding healthcare infrastructure, including hospitals, clinics, and long-term care facilities, increases the demand for infection control supplies. With the establishment of new facilities or the development of existing ones, the need to equip these spaces with the necessary supplies to maintain a sterile environment and prevent the spread of infections stands critical.
The overall infection control supplies market is categorized based on product, distribution channel, end-use, and region.
Based on product, the cleaning and disinfection equipment industry size will expand substantially through 2032. The increasing number of catheter-acquired urinary tract infections, in tandem with the growing financial burden associated with hospital-acquired infections, is paving the path for segment growth. As per NCBI, around 1 million cases of catheter-associated urinary tract infections (CAUTI) are diagnosed every year in the U.S. alone. Additionally, the associated cost of preventable CAUTI lies between the range of USD 115 million to USD 1.82 billion every year.
Based on the distribution channel, industry value from the e-commerce segment will depict substantial gains through 2032. Rising inclination of customers towards e-commerce channels owing to their convenience and cost-effectiveness is contributing to segment growth. Moreover, these platforms have high availability of a wide range of infection control supplies at discounted prices, which makes them suitable for the middle-class population. The rise in the number of e-commerce platforms is further creating a notable impetus for segment growth.
Based on the end-use, industry share from the medical device companies segment will grow at over 6% CAGR from 2023 to 2032. A surge in U.S. FDA approval of sterilization products has increased demand for infection control supplies in medical device companies. Moreover, tightening regulatory scenarios for infection control in healthcare settings has further increased the adoption of infection control supplies in these facilities.
From the regional standpoint, Europe infection control supplies market size will reach over USD 17 billion by 2032. Rising prevalence of chronic disorders attributed to the growing geriatric population is contributing to regional growth. Moreover, the robust presence of industry players such as Getinge Ab, Belimed Deutschland GmbH, and others is further working in favor of regional growth. Additionally, Europe has a well-established healthcare infrastructure that will support industry growth.